Engineered Multifunctional RGD-Gold Nanoparticles for the Detection of Tumour-Specific α(ν)β(3) Expression: Chemical Characterisation and Ecotoxicological Risk Assessment

$113.00 plus tax (Refund Policy)

Buy Article:

Abstract:

Radiolabelled nanoparticles conjugated to peptides that target specific molecules can be used as agents for diagnosis. For example, technetium-99m-labelled gold nanoparticles conjugated to the cyclic[Arg-Gly-Asp-Phe-Lys(Cys)] (c[RGDfK(C)]) peptide are used for the molecular imaging of tumour-specific α(ν)β(3) expression. Gold nanoparticles (AuNPs, 18–20 nm) are assumed to be safe at the concentrations used in diagnostic studies, and several studies of human toxicology and health implications have been discussed in a wide number of reports. However, no data are available on the potential ecotoxicity of radio-AuNPs conjugated to thiol-peptides after complete radionuclide decay. The aim of this study was to determine the ecotoxicological risk, measured by oxidative stress (OS) induction in Hyalella azteca , of a well-characterised multifunctional RGD-AuNP system (Tc-HYNIC-GGC-AuNP-c[RGDfK(C)]). TEM, UV-Vis, Raman, XPS, FT-IR and Far-IR spectroscopy techniques demonstrated that AuNPs were functionalised with the conjugated peptides. An acute toxicity test predicted an LC50 (72 h) of 1.83 cm2 per millilitre of medium. There were no statistically significant increases in OS and antioxidant defences after sub-acute exposure to a surface area concentration of 1/10 of the LC50. Tc-HYNIC-GGC-AuNP-c[RGDfK(C)] (20 nm) was demonstrated to be a chemically stable and nontoxic system in biological media after complete radionuclide decay because it does not promote the expression of OS and antioxidant defence enzymes, such as catalase, glutathione peroxidase and superoxide dismutase in Hyalella azteca.

Keywords: ECOTOXICOLOGY; GOLD NANOPARTICLES; HYALLELA AZTECA; NANOTECHNOLOGY; OXIDATIVE STRESS

Document Type: Research Article

DOI: http://dx.doi.org/10.1166/jbn.2012.1452

Publication date: December 1, 2012

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • ingentaconnect is not responsible for the content or availability of external websites

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more